4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-20-054351
Chief Financial Officer sold 30,000 shares at an average $50.65 ($1,519,429)
- Chief Financial Officer acquired 30,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cohen Chad M Chief Financial Officer | 2020-10-08 | Option exercise | +30,000 | $6.32 | $189,600 | 31,000 | D |
| Cohen Chad M Chief Financial Officer | 2020-10-08 | Sale | −23,746 | $50.46 | $1,198,223 | 7,254 | D |
| Cohen Chad M Chief Financial Officer | 2020-10-08 | Sale | −6,254 | $51.36 | $321,205 | 1,000 | D |
| Derivatives | |||||||
| Cohen Chad M Chief Financial Officer | 2020-10-08 | Option exercise · Stock Option (Right To Buy) | −30,000 | 550,000 | D | ||
| Open-market sales · 30,000 sh · avg $50.65 · $1,519,429 | |||||||
Loading xslF345X03/doc4.xml…